Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions

... National psoriasis Foundation data show more than half of those with psoriasis have other health issues PORTLAND, Ore., ... -- Emerging research reveals that people with psoriasis are at risk for developing other serious medical ...

Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn

... recognizes people with moderate to severe plaque psoriasis who have tried not to allow the condition to ... campaign designed to help people with plaque psoriasis get more information about managing their disease ... hundreds of people with moderate to severe plaque psoriasis have submitted video testimonials or personal ...

Psoriasis Cure Now Welcomes Institute of Medicine Report Urging 'Comparative Effectiveness' Research on Psoriasis, But Worries About Risk of Rationing

... the Institute of Medicine (IOM) for including psoriasis and psoriatic arthritis among its Top 100 health ... the effectiveness of various treatments for psoriasis among its Second Quartile priorities. According ... the IOM committee for including treatments for psoriasis and psoriatic arthritis among its priority ...

New Source of Information on Psoriasis Medications

... NeedyMeds.org and the National psoriasis Foundation announce a new source of information on psoriasis medications and the financial help available for ... page to its Web site tailored for those with psoriasis . The page is a psoriasis-specific source of help ...

Psoriasis Raises Risk of Heart Attack, Stroke, Death

... MONDAY, June 15 (HealthDay News) -- People with psoriasis face an increased risk of major cardiovascular ... disease (blockage of arteries in the legs) in the psoriasis group. The overall death rate for those with psoriasis was 86 percent higher than for those without the ...

American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications

... an extensive review of scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology ... of care for the management and treatment of psoriasis with traditional systemic therapies. ...

FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

... of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic ... product labeling is ongoing. About psoriasis psoriasis is a chronic, immune-mediated disease that ...

Psoriasis Patients Happy With Home-Based Treatment

... -- Home-based ultraviolet B (UVB) therapy for psoriasis is as effective and safe as outpatient ... University Medical Center Utrecht looked at 196 psoriasis patients who were randomly selected to use a UVB ... concluded. More information The National psoriasis Foundation has more about ...

Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis

... Ointment, Satisfying an Unmet Need Among psoriasis Patients - FORT WORTH, Texas, April 30 ... percent (47.1 percent) reported an improvement in psoriasis symptoms over the course of the 52-week trial. ... patients reported a noticeable improvement in psoriasis symptoms from baseline at week 26 (52.6 ...

SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... with inflamed, scaly, red patches of skin psoriasis and nail psoriasis. According to the National psoriasis Foundation, up to 30 percent of people with psoriasis also develop psoriatic arthritis. For additional ...

Having Psoriasis Raises Risk of Diabetes, Hypertension

... Previous research had indicated that psoriasis is associated with a higher risk of other ... diabetes at the start of the study. Women with psoriasis turned out to have a 63 percent increased risk of ... stated. So could the use of steroids to treat psoriasis although, they pointed out, this course of ...

Psoriasis Drug Raptiva Pulled From U.S. Market

... April 8 (HealthDay News) -- The troubled psoriasis drug Raptiva is being withdrawn from the U.S. ... medical officer. "Although we believe that many psoriasis patients are benefiting from Raptiva, the balance between benefit and risk in the psoriasis population for which Raptiva was approved has ...

Experts turn to Web to combat distressing skin disease

... People experiencing the skin disease psoriasis may get relief from their symptoms and the ... with coping." The eTIPS study, funded by the psoriasis Research Trust and supported by the psoriasis and Psoriatic Arthritis Alliance (PAPPAA), will ...

Low-Dose Acitretin May Reduce Nail Psoriasis

... Low-dose treatment with a drug used to treat skin psoriasis seems to help reduce nail psoriasis, according to ... As many as 78 percent of people with psoriasis have nail psoriasis, which includes irregular ... at least six months after treatment, and the Nail psoriasis Severity Index (NAPSI) was used to grade the ...

LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital

... disease. "I was first diagnosed with psoriasis at age 2 and throughout my childhood, my ... the negative effects of psoriasis." psoriasis is the most prevalent autoimmune disease in the ... affecting as many as 7.5 million Americans. psoriasis is a noncontagious, chronic, inflammatory, ...

Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis

... outperformed calcipotriol cream for control of psoriasis symptoms," said Alexa Kimball, MD, MPH, a CURTIS ... produced a significantly better reduction in psoriasis severity than calcipotriol therapy in 12 weeks ... patients reported better control of a range of psoriasis symptoms -- including scaling/flaking, redness, ...

American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies

... topical agents for patients with mild to moderate psoriasis SCHAUMBURG, Ill., March 2 ... of care for the management and treatment of psoriasis with topical therapies based on an extensive ... on the subject and recommendations of recognized psoriasis experts. This is the Academy's third of six ...

FDA Warns Users on Psoriasis Drug

... issued a public health advisory Thursday for the psoriasis drug Raptiva after confirming that three people ... Bebo Jr., director of research for the National psoriasis Foundation in Portland, Ore. "The risk to folks ... [and similar drugs] have very profound efficacy. psoriasis is a life-changing disease for many people, and a ...

Drug Reduces Inflammatory Arthritis Symptoms, Lesions

... of those in Group 2. Of the 124 patients with psoriasis affecting 3 percent or more body surface area, 33 ... 2 had a 75 percent or greater improvement in psoriasis area and severity index score at week 12 of the ... editorial. More information The National psoriasis Foundation has more about psoriatric arthritis . ...

Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill

... politics," said Michael Paranzino, president of psoriasis Cure Now. "It seems to have caught the patient ... wasted now will not cure cancer, arthritis or psoriasis tomorrow. Our Web site lets Americans concerned ... states being held up by a lack of funding. psoriasis Cure Now takes no position on whether the ...

Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis

... for the treatment of mild-to-moderate plaque psoriasis in adults. psoriasis is a chronic skin disorder that affects 2 to 3 ... on sensitive skin fold areas. "Because psoriasis is a chronic disease, topical products that are ...

Gene Insights May Improve Psoriasis Care

... The team looked for DNA changes in thousands of psoriasis patients and healthy people, and identified seven ... IL-213 pathway are already targeted by effective psoriasis therapies. Others, like the TNFAIP3 and TNIP1, may become targets for the psoriasis treatments of the future," co-principal ...

Scientists unmask genetic markers associated with psoriasis

... IL-23 pathway are already targeted by effective psoriasis therapies. Others, like TNFAIP3 and TNIP1, may become targets for the psoriasis treatments of the future." psoriasis affects some 7.5 million people in the United ...

An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe

... Decision Resources' Clinical Gold-Standard for psoriasis in 2012, According to a New Report from Decision ... agent for the treatment of moderate to severe psoriasis that demonstrates improved efficacy and lasting ... the performance of biological agents in the psoriasis market, oral therapies are still preferred by ...

Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings

... opportunities include: -- HUMIRA -- psoriasis -- Launched in Europe and the U.S. in 2008. -- RA Japan -- Launched in 2008. -- psoriasis Japan -- Indication filed, under regulatory ... promising results in early studies for psoriasis and is also being explored as a treatment ...

Obesity-Related Hormone Tied to Psoriasis

... MONDAY, Dec. 15 (HealthDay News) -- People with psoriasis have higher levels of the obesity-related hormone ... shows. The Taiwanese study included 77 psoriasis patients and a control group of 81 people without ... role in immune and inflammatory processes. The psoriasis patients were more likely than those in the ...

Biologic Drugs, Particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017

... Percentage of Biologic-Treated psoriasis Patients Will Double by 2017, According to a New ... Humira, will drive the moderate to severe psoriasis drug market to more than double to nearly $5 ... The new Pharmacor report entitled psoriasis finds that the ...

Indigo Ointment Benefits Psoriasis Patients

... They studied 42 people with treatment-resistant psoriasis who were treated with an ointment made from ... who completed the study experienced worsening psoriasis in the areas treated with the indigo ointment, ... Academy of Family Physicians has more about psoriasis . -- Robert ...

National Psoriasis Foundation Seeks 10,000 Americans to Support Psoriasis Research for World Psoriasis Day

... -- For World Psoriasis Day, Oct. 29, the National psoriasis Foundation wants 10,000 Americans to visit its ... on the skin. During the fifth annual World psoriasis Day, awareness activities will occur all over the ... access to treatments and build unity among the psoriasis and psoriatic arthritis community. "Over the ...

National Psoriasis Foundation Releases 2008 Study Results

... psoriasis is a significant problem in daily life, survey ... of people living with psoriasis say the disease is a significant problem in daily ... today. The survey of 426 individuals with psoriasis and psoriatic arthritis also revealed that their ...

After Fits and Starts, New Hope for Psoriasis Patients

... Doctors tout drugs called biologics during psoriasis Awareness Month MONDAY, Aug. 25 (HealthDay News) -- psoriasis can be a maddening disease. Patches of thick, ... the worse the person suffers. And because psoriasis is a genetic condition that causes inflammation ...

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... with inflamed, scaly, red patches of skin psoriasis and psoriasis nail involvement. Symptoms may include stiffness ... feet, lower back and neck are commonly affected. psoriasis affects an estimated two to three percent of the ...

FDA Panel Recommends Enbrel for Pediatric Patients

... But experts also express concern about psoriasis drug's possible risks for children; action ... advisory panel recommended Wednesday that the psoriasis drug Enbrel be approved for use in children who ... rheumatoid arthritis in adults and children, and psoriasis in adults only. The agency staff said Monday ...

Dermatologists Release Psoriasis Care Guidelines

... guidelines for the management of mild to severe psoriasis and psoriatic arthritis released by the American ... that pinpoint immune responses involved with psoriasis and psoriatic arthritis. About 6 million to 7 ... in a prepared statement. "The guidelines for psoriasis and psoriatic arthritis, which focus on the use ...

American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis

... new guidelines of care for the management of psoriasis and psoriatic arthritis based on an ... of the American Academy of Dermatology, the new psoriasis and psoriatic guidelines present the ... president of the Academy. "The guidelines for psoriasis and psoriatic arthritis, which focus on the use ...

Drug Works Well for Moderate-to-Severe Psoriasis

... and long-term treatment for moderate-to-severe psoriasis in two studies published in this week's issue of ... two-thirds of patients with moderate-to-severe psoriasis achieved at least a 75 percent improvement in ... dose did much better in retaining their improved psoriasis condition. "Our results suggest that ...

FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis

... it over the useful life of the product. psoriasis is a chronic, inflammatory skin disease for which there is no cure. In plaque psoriasis (psoriasis vulgaris), the most common ... silvery white scales. A non-contagious disorder, psoriasis can occur on any part of the body, and can ...

New In-Depth Informative Website Launched for People With Psoriasis and Psoriatic Arthritis

... -- On the 1st of May 2008, UK charity, the psoriasis and Psoriatic Arthritis Alliance (PAPAA) ... banner of The Principal Source of Information for psoriasis and Psoriatic Arthritis. PAPAA is providing an ... with real input from people with or affected by psoriasis and psoriatic arthritis. David Chandler PAPAA ...

New Psoriasis Pill Appears Effective

... A new drug for patients with moderate to severe psoriasis appears to be safe and effective, a Canadian ... for psoriasis, the researchers said. psoriasis is an autoimmune skin disease. The most common ... one of the most effective treatments for psoriasis is the calcineurin inhibitor drug ciclosporin. ...

Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook

... five key regulatory approvals: HUMIRA for psoriasis and for juvenile rheumatoid arthritis, ... * HUMIRA(R) Indications Approved o psoriasis -- Abbott received FDA approval for HUMIRA to ... achieved a 75 percent reduction in psoriasis ....